Normal intrinsic Th1/Th2 balance in patients with chronic phase chronic myeloid leukemia not treated with interferon-α or imatinib

被引:0
作者
Kiani, A
Habermann, I
Schakel, K
Neubauer, A
Rogge, L
Ehninger, G
机构
[1] Tech Univ Dresden, Med Klin & Poliklin 1, D-01307 Dresden, Germany
[2] Tech Univ Dresden, Dept Med, D-01307 Dresden, Germany
[3] Tech Univ Dresden, Inst Immunol, D-01307 Dresden, Germany
[4] Tech Univ Dresden, Univ Hosp Carl Gustav Carus, D-01307 Dresden, Germany
[5] Univ Marburg, Univ Hosp, Dept Hematol Oncol & Immunol, Marburg, Germany
[6] Inst Pasteur, Dept Immunol, F-75724 Paris, France
关键词
chronic myeloid leukemia; T-helper cells; Th1; Th2; IL-10;
D O I
暂无
中图分类号
R5 [内科学];
学科分类号
1002 ; 100201 ;
摘要
Background and Objectives. CD4(+) T helper cells are an integral part of effective immune responses against various malignancies; however in tumor-bearing patients they are frequently functionally unresponsive. T helper cells of patients with chronic myeloid leukemia (CML), analyzed as part of mononuclear cell fractions, show a loss of signaling molecules, a compromised Th1 cytokine production and a shift towards a non-productive Th2 state. The underlying mechanism is unknown and may involve intrinsic T cell defects as well as indirect effects mediated by leukemia or antigen-presenting cells. The purpose of the present study was to analyze the intrinsic cytokine-producing capacity of purified CIVIL T helper cells in the absence of other cell types. Design and Methods. Untouched CD4(+) T cells with a purity of more than 90% were isolated from 10 patients with Ph+ chronic phase CML on maintenance treatment with hydroxyurea. The cells were isolated by density gradient centrifugation followed by immunomagnetic depletion of leukemia and accessory cells. The ex vivo cytokine-producing capacity of CML T helper cells in response to polyclonal stimulation with anti-CD3 and anti-CD28 was then compared to that of cells purified from matched healthy volunteers. Results. T helper cells purified from CML patients produced comparable amounts of the Th1 cytokines interleukin (IL)-2 and interferon (IFN)-gamma as tells purified from healthy volunteers. Likewise, no difference between CML and control T helper cells was found with respect to the Th2 cytokines, IL-4 and IL-13, as well as the immunomodulatory cytokine, IL-10. Interpretation and Conclusions. In the absence of leukemia and accessory cells, the intrinsic cytokine-producing capacity of CML T helper cells is normal. A Th2 shift was not detected, and the predominant presence of an IL-10-producing, immunosuppressive T helper cell subset could be excluded.
引用
收藏
页码:754 / 761
页数:8
相关论文
共 32 条
  • [1] Functional diversity of helper T lymphocytes
    Abbas, AK
    Murphy, KM
    Sher, A
    [J]. NATURE, 1996, 383 (6603) : 787 - 793
  • [2] Toxicity and efficacy of defined doses of CD4+ donor lymphocytes for treatment of relapse after allogeneic bone marrow transplant
    Alyea, EP
    Soiffer, RJ
    Canning, C
    Neuberg, D
    Schlossman, R
    Pickett, C
    Collins, H
    Wang, YL
    Anderson, KC
    Ritz, J
    [J]. BLOOD, 1998, 91 (10) : 3671 - 3680
  • [3] BONE-MARROW TRANSPLANTATION FOR CHRONIC MYELOID-LEUKEMIA IN 1ST CHRONIC PHASE - IMPORTANCE OF A GRAFT-VERSUS-LEUKEMIA EFFECT
    APPERLEY, JF
    MAURO, FR
    GOLDMAN, JM
    GREGORY, W
    ARTHUR, CK
    HOWS, J
    ARCESE, W
    PAPA, G
    MANDELLI, F
    WARDLE, D
    GRAVETT, P
    FRANKLIN, IM
    BANDINI, G
    RICCI, P
    TURA, S
    IACONE, A
    TORLONTANO, G
    HEIT, W
    CHAMPLIN, R
    GALE, RP
    [J]. BRITISH JOURNAL OF HAEMATOLOGY, 1988, 69 (02) : 239 - 245
  • [4] Bertazzoli C, 2000, CLIN CANCER RES, V6, P1931
  • [5] BIERNAUX C, 1995, BLOOD, V86, P3118
  • [6] Buggins AGS, 1998, BRIT J HAEMATOL, V100, P784
  • [7] Impaired expression of the CD3-zeta chain in peripheral blood T cells of patients with chronic myeloid leukaemia results in an increased susceptibility to apoptosis
    Chen, X
    Woiciechowsky, A
    Raffegerst, S
    Schendel, D
    Kolb, HJ
    Roskrow, M
    [J]. BRITISH JOURNAL OF HAEMATOLOGY, 2000, 111 (03) : 817 - 825
  • [8] Mechanisms of disease - The biology of chronic myeloid leukemia
    Faderl, S
    Talpaz, M
    Estrov, Z
    O'Brien, S
    Kurzrock, R
    Kantarjian, HM
    [J]. NEW ENGLAND JOURNAL OF MEDICINE, 1999, 341 (03) : 164 - 172
  • [9] THERAPY OF DISSEMINATED MURINE LEUKEMIA WITH CYCLOPHOSPHAMIDE AND IMMUNE LYT-1+,2- T-CELLS - TUMOR-ERADICATION DOES NOT REQUIRE PARTICIPATION OF CYTO-TOXIC T-CELLS
    GREENBERG, PD
    KERN, DE
    CHEEVER, MA
    [J]. JOURNAL OF EXPERIMENTAL MEDICINE, 1985, 161 (05) : 1122 - 1134
  • [10] A CD4(+) T-cell subset inhibits antigen-specific T-cell responses and prevents colitis
    Groux, H
    OGarra, A
    Bigler, M
    Rouleau, M
    Antonenko, S
    deVries, JE
    Roncarolo, MG
    [J]. NATURE, 1997, 389 (6652) : 737 - 742